Southern Research has signed an agreement with Apath, LLC to conduct lab testing, research, and/or screening of potential therapeutic agents for hepatitis C (HCV) on an exclusive, fee-for-service basis using Apath’s HCV virus-based technology. Using a virus-based system, researchers can now develop antiviral treatments targeting viral entry into the cell, all of the replication machinery, as well as downstream events such as viral assembly and release from the cell. “Preclinical screening usin...